Aldeyra Therapeutics Inc
ALDX
Get informed when a big investor buys or sells
+ FollowMarket Cap$93.5M
Close$
$0.91
37% downside
Current Fair Value
37% downsideOvervalued by 37% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $93.50 Million |
|---|---|
| Enterprise Value | $-38,946,245,502,345.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.56 |
| Beta | 1.15 |
| Outstanding Shares | 60,321,000 |
Return
| Return on Equity | -43.79% |
|---|---|
| Return on Assets | -34.90% |
| Return on Invested Capital | -45.92% |
Valuation & Multiples
| P/E Ratio | -4 |
|---|---|
| PEG | 9.06 |
| Price to Sales | - |
| Price to Book Ratio | 0.0 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | 2.24 |
| Enterprise Value to Net Income | 2 |
| Total Debt to Enterprise | -0.16 |
| Debt to Equity | 0.16 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 6, 2026
EPS Estimate
$-0.09
Average shareholder expectationRevenue Estimate
$31.33 M
Average shareholder expectationNext Earnings Call
Expected Date
November 4, 2026
EPS Estimate
$-0.08
Average shareholder expectationRevenue Estimate
$2.50 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.5099▲ 20.79% |
|---|---|
| Total Calls | 640,100▲ 2.24% |
| Total Puts | 326,400▲ 72.61% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 62.06%▼ 2.70% |
|---|---|
| Total Invested | $63.33M▼ 68.61% |
| Investors Holding | 135▼ 9.00% |
ESG Score
No data